A detailed history of Tiaa Trust, National Association transactions in Geron Corp stock. As of the latest transaction made, Tiaa Trust, National Association holds 58,310 shares of GERN stock, worth $231,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,310
Previous 58,250 0.1%
Holding current value
$231,490
Previous $246,000 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.17 - $4.99 $250 - $299
60 Added 0.1%
58,310 $264,000
Q3 2023

Oct 27, 2023

BUY
$2.11 - $3.28 $122,907 - $191,060
58,250 New
58,250 $123,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.5B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Tiaa Trust, National Association Portfolio

Follow Tiaa Trust, National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa Trust, National Association, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa Trust, National Association with notifications on news.